These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21622243)

  • 21. CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines.
    Sana J; Zambo I; Skoda J; Neradil J; Chlapek P; Hermanova M; Mudry P; Vasikova A; Zitterbart K; Hampl A; Sterba J; Veselska R
    Anal Cell Pathol (Amst); 2011; 34(6):303-18. PubMed ID: 22156015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of CD133+/nestin+ putative cancer stem cells in non-small cell lung cancer.
    Janikova M; Skarda J; Dziechciarkova M; Radova L; Chmelova J; Krejci V; Sedlakova E; Zapletalova J; Langova K; Klein J; Grygarkova I; Kolek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Dec; 154(4):321-6. PubMed ID: 21293543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD10 expression by melanoma cells is associated with aggressive behavior in vitro and predicts rapid metastatic progression in humans.
    Thomas-Pfaab M; Annereau JP; Munsch C; Guilbaud N; Garrido I; Paul C; Brousset P; Lamant L; Meyer N
    J Dermatol Sci; 2013 Feb; 69(2):105-13. PubMed ID: 23219141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stable expression of FoxA1 promotes pluripotent P19 embryonal carcinoma cells to be neural stem-like cells.
    Dong D; Meng L; Yu Q; Tan G; Ding M; Tan Y
    Gene Expr; 2012; 15(4):153-62. PubMed ID: 22783724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Girdin maintains the stemness of glioblastoma stem cells.
    Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
    Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and characterization of spheroid cells from human malignant melanoma cell line WM-266-4.
    Na YR; Seok SH; Kim DJ; Han JH; Kim TH; Jung H; Lee BH; Park JH
    Tumour Biol; 2009; 30(5-6):300-9. PubMed ID: 19940551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.
    Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM
    Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of cancer stem cells from the C6 glioma cell line.
    Zhou XD; Wang XY; Qu FJ; Zhong YH; Lu XD; Zhao P; Wang DH; Huang QB; Zhang L; Li XG
    J Int Med Res; 2009; 37(2):503-10. PubMed ID: 19383245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma.
    Sharma BK; Manglik V; O'Connell M; Weeraratna A; McCarron EC; Broussard JN; Divito KA; Simbulan-Rosenthal CM; Rosenthal DS; Zapas JL
    Int J Oncol; 2012 Nov; 41(5):1570-6. PubMed ID: 22922842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.
    Kryczek I; Liu S; Roh M; Vatan L; Szeliga W; Wei S; Banerjee M; Mao Y; Kotarski J; Wicha MS; Liu R; Zou W
    Int J Cancer; 2012 Jan; 130(1):29-39. PubMed ID: 21480217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo.
    deCarvalho AC; Nelson K; Lemke N; Lehman NL; Arbab AS; Kalkanis S; Mikkelsen T
    Stem Cells; 2010 Feb; 28(2):181-90. PubMed ID: 19937755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Correlative study of distribution of brain tumor stem cell with micro-vascular system].
    Li MW; Niu CS
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.
    Monzani E; Facchetti F; Galmozzi E; Corsini E; Benetti A; Cavazzin C; Gritti A; Piccinini A; Porro D; Santinami M; Invernici G; Parati E; Alessandri G; La Porta CA
    Eur J Cancer; 2007 Mar; 43(5):935-46. PubMed ID: 17320377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colon cancer stem cells: implications in carcinogenesis.
    Sanders MA; Majumdar AP
    Front Biosci (Landmark Ed); 2011 Jan; 16(5):1651-62. PubMed ID: 21196254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells.
    Taghizadeh R; Noh M; Huh YH; Ciusani E; Sigalotti L; Maio M; Arosio B; Nicotra MR; Natali P; Sherley JL; La Porta CA
    PLoS One; 2010 Dec; 5(12):e15183. PubMed ID: 21203549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the biological characteristics of glioma cancer stem cells after serial in vivo subtransplantation.
    Shin GY; Shim JK; Lee JH; Shin HJ; Lee SJ; Huh YM; Kim EH; Park EK; Kim SH; Chang JH; Kim DS; Hong YK; Kim SH; Kang SG; Lang FF
    Childs Nerv Syst; 2013 Jan; 29(1):55-64. PubMed ID: 23143001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD133 as a marker for cancer stem cells: progresses and concerns.
    Wu Y; Wu PY
    Stem Cells Dev; 2009 Oct; 18(8):1127-34. PubMed ID: 19409053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Finding markers for cancer stem cells in renal cell carcinoma: looking beyond CD133.
    Ottaiano A
    Cell Cycle; 2010 Nov; 9(22):4431. PubMed ID: 21088484
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.